These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8242398)
21. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway. Andrés ME; Gysling K; Bustos G Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143 [TBL] [Abstract][Full Text] [Related]
22. 1-Hydroxy-3-aminopyrrolid-2-one (HA-966) and kynurenate antagonize N-methyl-D-aspartate induced enhancement of [3H]dopamine release from rat striatal slices. Crawford M; Roberts PJ Biochem Pharmacol; 1989 Dec; 38(23):4165-8. PubMed ID: 2688655 [TBL] [Abstract][Full Text] [Related]
23. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. Albers DS; Sonsalla PK J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070 [TBL] [Abstract][Full Text] [Related]
24. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition. Fossom LH; Basile AS; Skolnick P Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014 [TBL] [Abstract][Full Text] [Related]
25. Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway. Shimizu S; Sogabe S; Yanagisako R; Inada A; Yamanaka M; Iha HA; Ohno Y Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671605 [TBL] [Abstract][Full Text] [Related]
26. MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum. Muraki A; Koyama T; Nakayama M; Ohmori T; Yamashita I Neurosci Lett; 1992 Feb; 136(1):39-42. PubMed ID: 1353257 [TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effect of riluzole in MPTP-treated mice. Araki T; Kumagai T; Tanaka K; Matsubara M; Kato H; Itoyama Y; Imai Y Brain Res; 2001 Nov; 918(1-2):176-81. PubMed ID: 11684056 [TBL] [Abstract][Full Text] [Related]
29. Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures. Newell DW; Barth A; Malouf AT Brain Res; 1995 Mar; 675(1-2):38-44. PubMed ID: 7796152 [TBL] [Abstract][Full Text] [Related]
30. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity. Bourque M; Liu B; Dluzen DE; Di Paolo T Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264 [TBL] [Abstract][Full Text] [Related]
32. NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study. Kiss JP; Tóth E; Lajtha A; Vizi ES Brain Res; 1994 Mar; 641(1):145-8. PubMed ID: 8019840 [TBL] [Abstract][Full Text] [Related]
33. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors. Danysz W; Fadda E; Wroblewski JT; Costa E Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820 [TBL] [Abstract][Full Text] [Related]
34. Interactions of MK-801 with glutamate-, glutamine- and methamphetamine-evoked release of [3H]dopamine from striatal slices. Bowyer JF; Scallet AC; Holson RR; Lipe GW; Slikker W; Ali SF J Pharmacol Exp Ther; 1991 Apr; 257(1):262-70. PubMed ID: 1673475 [TBL] [Abstract][Full Text] [Related]
35. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Trullas R; Skolnick P Eur J Pharmacol; 1990 Aug; 185(1):1-10. PubMed ID: 2171955 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine. Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T Life Sci; 2000 Aug; 67(13):1559-71. PubMed ID: 10983851 [TBL] [Abstract][Full Text] [Related]
37. Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst. Imam SZ; Crow JP; Newport GD; Islam F; Slikker W; Ali SF Brain Res; 1999 Aug; 837(1-2):15-21. PubMed ID: 10433983 [TBL] [Abstract][Full Text] [Related]
38. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. Nowak G; Trullas R; Layer RT; Skolnick P; Paul IA J Pharmacol Exp Ther; 1993 Jun; 265(3):1380-6. PubMed ID: 8099620 [TBL] [Abstract][Full Text] [Related]
39. In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Santiago M; Venero JL; Machado A; Cano J Brain Res; 1992 Jul; 586(2):203-7. PubMed ID: 1521154 [TBL] [Abstract][Full Text] [Related]
40. Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice. Kupsch A; Löschmann PA; Sauer H; Arnold G; Renner P; Pufal D; Burg M; Wachtel H; ten Bruggencate G; Oertel WH Brain Res; 1992 Oct; 592(1-2):74-83. PubMed ID: 1360317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]